Viking Therapeutics (VKTX) Shares Issued (2015 - 2026)
Viking Therapeutics (VKTX) posted Shares Issued of $6.0 million for Q2 2026, up 0.86% sequentially from $5.9 million in Q1 2026, and up 15.51% YoY from $5.2 million in Q2 2025.
Viking Therapeutics (VKTX) Shares Issued (2015 - 2026) Analysis & Trends
Viking Therapeutics has reported Shares Issued for 12 years, with the latest figure at $6.0 million in Q2 2026.
- Quarterly Shares Issued rose 15.51% year-over-year to $6.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $6.0 million (up 15.51% YoY) and the FY2025 annual result came in at $5.1 million, up 8.03% from the prior year.
- Shares Issued improved to $6.0 million in Q2 2026 per VKTX's latest filing, from $5.9 million in the prior quarter.
- Over five years, Shares Issued peaked at $6.0 million in Q2 2026 and troughed at $4.7 million in Q4 2024.
- A 5-year average of $5.3 million and a median of $5.2 million in 2023 frame the typical range for Shares Issued.
- The sharpest annual moves came in 2022 and 2024: Shares Issued jumped 30.17% in 2022, then declined 9.8% in 2024.
- Over 5 years, Shares Issued stood at $5.2 million in 2022, then climbed by 1.76% to $5.2 million in 2023, then slipped by 9.8% to $4.7 million in 2024, then grew by 8.03% to $5.1 million in 2025, then advanced by 17.11% to $6.0 million in 2026.
- According to Business Quant data, Shares Issued over the past three periods registered $6.0 million, $5.9 million, and $5.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 18.36 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Viking Therapeutics | 3.87 Bn | 3.87 Bn | - | 5.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.99 Mn |
| Jun 30, 2026 | 5.99 Mn |
| Mar 31, 2026 | 5.94 Mn |
| Mar 31, 2026 | 5.94 Mn |
| Dec 31, 2025 | 5.11 Mn |
| Dec 31, 2025 | 5.11 Mn |
| Sep 30, 2025 | 5.17 Mn |
| Sep 30, 2025 | 5.17 Mn |
| Jun 30, 2025 | 5.19 Mn |
| Jun 30, 2025 | 5.19 Mn |
| Mar 31, 2025 | 5.18 Mn |
| Mar 31, 2025 | 5.18 Mn |
| Dec 31, 2024 | 4.73 Mn |
| Dec 31, 2024 | 4.73 Mn |
| Sep 30, 2024 | 4.86 Mn |
| Sep 30, 2024 | 4.86 Mn |
| Jun 30, 2024 | 5.12 Mn |
| Jun 30, 2024 | 5.12 Mn |
| Mar 31, 2024 | 5.52 Mn |
| Mar 31, 2024 | 5.52 Mn |